Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Osteoporosis

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 122 articles:
HTML format



Single Articles


    March 2024
  1. STOKAR J, Szalat A
    Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
    J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210.
    PubMed     Abstract available


    February 2024
  2. TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al
    More rapid bone mineral density loss in older men with diabetes: The Osteoporotic Fractures in Men (MrOS) Study.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210.
    PubMed     Abstract available


  3. MORI Y, Mori N
    Letter to the Editor From Mori and Mori: "Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis".
    J Clin Endocrinol Metab. 2024 Feb 9:dgae083. doi: 10.1210.
    PubMed    


    January 2024
  4. MINISOLA S, Cipriani C, Colangelo L, Pepe J, et al
    At the Intersection Between Skeletal and Hematopoietic Systems: Incorporating Hemoglobin in FRAX(R).
    J Clin Endocrinol Metab. 2024;109:e856-e857.
    PubMed    


  5. BAUER DC, Black DM, Dell R, Fan B, et al
    Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case Cohort Study with Blinded Radiographic Review.
    J Clin Endocrinol Metab. 2024 Jan 10:dgae023. doi: 10.1210.
    PubMed     Abstract available


    December 2023
  6. STYRKARSDOTTIR U, Tragante V, Stefansdottir L, Thorleifsson G, et al
    Obesity variants in the GIPR gene do not associate with risk of fracture or bone mineral density.
    J Clin Endocrinol Metab. 2023 Dec 20:dgad734. doi: 10.1210.
    PubMed     Abstract available


  7. PRINCE RL
    New Data on the Increased hip Fracture Risk in Type 2 Diabetes and Its Reduction in Those With High Physical Activity.
    J Clin Endocrinol Metab. 2023 Dec 14:dgad712. doi: 10.1210.
    PubMed    


    November 2023
  8. WANG M, Seibel MJ
    Approach to the Patient With Bone Fracture: Making the First Fracture the Last.
    J Clin Endocrinol Metab. 2023;108:3345-3352.
    PubMed     Abstract available


    October 2023
  9. ZHANG X, Chen X, Li S, Gao M, et al
    Association between advanced glycation end products and sarcopenia: The mediating role of osteoporosis.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad640. doi: 10.1210.
    PubMed     Abstract available


    September 2023
  10. FAVERO V, Eller-Vainicher C, Morelli V, Cairoli E, et al
    Increased risk of vertebral fractures in patients with mild autonomous cortisol secretion.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad560. doi: 10.1210.
    PubMed     Abstract available


  11. ANAGNOSTIS P, Lampropoulou-Adamidou K, Bosdou JK, Trovas G, et al
    Comparative effectiveness of therapeutic interventions in pregnancy and lactation-associated osteoporosis: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2023 Sep 14:dgad548. doi: 10.1210.
    PubMed     Abstract available


    August 2023
  12. FLOKAS ME, Wakim P, Kollender S, Sinaii N, et al
    Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2023 Aug 29:dgad514. doi: 10.1210.
    PubMed     Abstract available


  13. RAMCHAND SK, Leder BZ
    Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad496. doi: 10.1210.
    PubMed     Abstract available


  14. PHUNG K, McAdam L, Ma J, McMillan HJ, et al
    Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad435. doi: 10.1210.
    PubMed     Abstract available


  15. SZULC P, Lewis JR, Chapurlat R
    Accelerated bone loss in older men with severe abdominal aortic calcification - the prospective MINOS study.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad459. doi: 10.1210.
    PubMed     Abstract available


  16. CHILOIRO S, Frara S, Gagliardi I, Bianchi A, et al
    Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly.
    J Clin Endocrinol Metab. 2023 Aug 22:dgad493. doi: 10.1210.
    PubMed     Abstract available


  17. SOTO-PEDRE E, Lin YY, Soto-Hernaez J, Newey PJ, et al
    Morbidity Associated With Primary Hyperparathyroidism-A Population-based Study With a Subanalysis on Vitamin D.
    J Clin Endocrinol Metab. 2023;108:e842-e849.
    PubMed     Abstract available


  18. LIN SY, Chen WJ, Ku CK, Chen YM, et al
    Treatment Persistence and Medication Switch Associated with Subsequent Fractures after Osteoporotic Fractures.
    J Clin Endocrinol Metab. 2023 Aug 1:dgad449. doi: 10.1210.
    PubMed     Abstract available


    July 2023
  19. LABAYEN I, Cadenas-Sanchez C, Idoate F, Medrano M, et al
    Liver fat, bone marrow adipose tissue and bone mineral density in children with overweight.
    J Clin Endocrinol Metab. 2023 Jul 25:dgad429. doi: 10.1210.
    PubMed     Abstract available


  20. CAPPOLA AR, Auchus RJ, El-Hajj Fuleihan G, Handelsman DJ, et al
    Hormones and Aging: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2023;108:1835-1874.
    PubMed     Abstract available


  21. TRINH A, Milat F
    Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial.
    J Clin Endocrinol Metab. 2023 Jul 12:dgad386. doi: 10.1210.
    PubMed    


  22. JAISWAL R, Johansson H, Axelsson KF, Magnusson P, et al
    Hemoglobin levels improve fracture risk prediction in addition to FRAX(R) clinical risk factors and bone mineral density.
    J Clin Endocrinol Metab. 2023 Jul 5:dgad399. doi: 10.1210.
    PubMed     Abstract available


    June 2023
  23. WATTS NB, Leslie WD
    Letter to the Editor from Watts and William: Comparisons between different anti-osteoporosis medications on postfracture mortality: a population-based study.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad317. doi: 10.1210.
    PubMed    


    May 2023
  24. GRANILD-JENSEN JB, Moller-Madsen B, Rackauskaite G, Farholt S, et al
    Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial.
    J Clin Endocrinol Metab. 2023 May 26:dgad299. doi: 10.1210.
    PubMed     Abstract available


  25. CARBONE L, Buzkova P, Fink HA, Robbins JA, et al
    Plasma Levels of Branched Chain Amino Acids, Incident Hip Fractures and Bone Mineral Density of the Hip and Spine.
    J Clin Endocrinol Metab. 2023 May 18:dgad275. doi: 10.1210.
    PubMed     Abstract available


  26. SKJODT MK, Abrahamsen B
    New insights in the pathophysiology, epidemiology and response to treatment of osteoporotic vertebral fractures.
    J Clin Endocrinol Metab. 2023 May 15:dgad256. doi: 10.1210.
    PubMed     Abstract available


  27. HO-LE TP, Tran TS, Nguyen HG, Center JR, et al
    Genetic prediction of lifetime risk of fracture.
    J Clin Endocrinol Metab. 2023 May 11:dgad254. doi: 10.1210.
    PubMed     Abstract available


  28. MEIER C, Eastell R, Pierroz DD, Lane NE, et al
    Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS.
    J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210.
    PubMed     Abstract available


  29. MEIER C, Eastell R, Pierroz DD, Lane NE, et al
    Biochemical Markers of Bone Fragility in Patients With Diabetes.
    J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210.
    PubMed     Abstract available


    April 2023
  30. PACCOU J, Badr S, Lombardo D, Khizindar H, et al
    Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women: The ADIMOS Case-Control Study.
    J Clin Endocrinol Metab. 2023 Apr 5:dgad195. doi: 10.1210.
    PubMed     Abstract available


    March 2023
  31. FAN W, Leder BZ, Bolster MB
    Response to Letter to the Editor from Riahi and Gruntmanis: 'Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates'.
    J Clin Endocrinol Metab. 2023 Mar 22:dgad161. doi: 10.1210.
    PubMed    


  32. RIAHI S, Gruntmanis U
    "Letter to the Editor from Riahi and Gruntmanis: 'Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates'.
    J Clin Endocrinol Metab. 2023 Mar 22:dgad162. doi: 10.1210.
    PubMed    


    February 2023
  33. HEILBRONNER AK, Koff MF, Breighner R, Kim HJ, et al
    Opportunistic Evaluation of Trabecular Bone Texture by MRI Reflects Bone Mineral Density and Microarchitecture.
    J Clin Endocrinol Metab. 2023 Feb 17:dgad082. doi: 10.1210.
    PubMed     Abstract available


    January 2023
  34. LIU W, Lee B, Nagamani SCS, Nicol L, et al
    Approach to the Patient: Pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta.
    J Clin Endocrinol Metab. 2023 Jan 20:dgad035. doi: 10.1210.
    PubMed     Abstract available


  35. ZENG H, Ge J, Xu W, Ma H, et al
    Twelve Loci Associated With Bone Density in Middle-aged and Elderly Chinese: The Shanghai Changfeng Study.
    J Clin Endocrinol Metab. 2023;108:295-305.
    PubMed     Abstract available


  36. HU J, Lin X, Gao P, Zhang Q, et al
    Genotypic and phenotypic spectrum and pathogenesis of WNT1 variants in a large cohort of patients with OI/osteoporosis.
    J Clin Endocrinol Metab. 2023 Jan 3:dgac752. doi: 10.1210.
    PubMed     Abstract available


    December 2022
  37. VAN ABSWOUDE DH, Pellikaan K, Rosenberg AGW, Davidse K, et al
    Bone Health in Adults With Prader-Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study.
    J Clin Endocrinol Metab. 2022;108:59-84.
    PubMed     Abstract available


  38. ADLER RA
    Osteoporosis Treatment: Decreased Mortality Too?
    J Clin Endocrinol Metab. 2022 Dec 15:dgac723. doi: 10.1210.
    PubMed    


  39. WANG M, Chen X, Cui W, Wang X, et al
    A computed tomography-based radiomics nomogram for predicting osteoporotic vertebral fractures: A longitudinal study.
    J Clin Endocrinol Metab. 2022 Dec 10:dgac722. doi: 10.1210.
    PubMed     Abstract available


  40. DIMAI HP
    New Horizons: AI tools for managing osteoporosis.
    J Clin Endocrinol Metab. 2022 Dec 8:dgac702. doi: 10.1210.
    PubMed     Abstract available


    November 2022
  41. GAGNON C
    Reduced Intestinal Calcium Absorption Correlates with Bone Loss After Sleeve Gastrectomy: Implications for Clinical Care.
    J Clin Endocrinol Metab. 2022 Nov 24:dgac681. doi: 10.1210.
    PubMed    


  42. MESSNER Z, Carro-Vazquez D, Haschka J, Grillari J, et al
    Circulating miRNAs Respond to Denosumab Treatment after Two Years in Postmenopausal Women with Osteoporosis.
    J Clin Endocrinol Metab. 2022 Nov 19:dgac667. doi: 10.1210.
    PubMed     Abstract available


  43. WU CH, Li CC, Hsu YH, Liang FW, et al
    Comparisons between different anti-osteoporosis medications on postfracture mortality: A population-based study.
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785916. doi: 10.1210.
    PubMed     Abstract available


    October 2022
  44. KLINE GA, Morin SN, Lix LM, McCloskey EV, et al
    General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study.
    J Clin Endocrinol Metab. 2022 Oct 6. pii: 6750025. doi: 10.1210.
    PubMed     Abstract available


    September 2022
  45. REID IR
    How Often Should We Measure Bone Density?
    J Clin Endocrinol Metab. 2022;107:e4267-e4268.
    PubMed    


  46. FAN W, Machado M, Leder BZ, Beyer L, et al
    Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691222. doi: 10.1210.
    PubMed     Abstract available


  47. LI I, Hartley IR, Klubo-Gwiedzdzinska J, Reynolds JC, et al
    Fracture Risk in Pediatric Patients with MEN2B.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691128. doi: 10.1210.
    PubMed     Abstract available


    August 2022
  48. SINGH S, Morshed S, Motamedi D, Kidane J, et al
    Identification of Risk Factors in the Development of Heterotopic Ossification After Primary Total Hip Arthroplasty.
    J Clin Endocrinol Metab. 2022;107:e3944-e3952.
    PubMed     Abstract available


  49. MATSUMOTO T, Sone T, Soen S, Tanaka S, et al
    Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study.
    J Clin Endocrinol Metab. 2022 Aug 17. pii: 6670847. doi: 10.1210.
    PubMed     Abstract available


    July 2022
  50. LYU H, Zhao S, Li J, Li X, et al
    Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:e3366-e3373.
    PubMed     Abstract available


    June 2022
  51. OHEIM R, Tsourdi E, Seefried L, Beller G, et al
    Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
    J Clin Endocrinol Metab. 2022;107:e3048-e3057.
    PubMed     Abstract available


    May 2022
  52. ENSRUD KE, Lui LY, Crandall CJ, Orwoll ES, et al
    Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2022 May 19. pii: 6589466. doi: 10.1210.
    PubMed     Abstract available


  53. COMNINOS AN, Hansen MS, Courtney A, Choudhury S, et al
    Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
    J Clin Endocrinol Metab. 2022;107:1529-1540.
    PubMed     Abstract available


  54. CIUFFI S, Marini F, Fossi C, Donati S, et al
    Circulating microRNAs as biomarkers of osteoporosis and fragility fractures.
    J Clin Endocrinol Metab. 2022 May 9. pii: 6582745. doi: 10.1210.
    PubMed     Abstract available


  55. CARWILE JL, Seshasayee SM, Ahrens KA, Hauser R, et al
    Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.
    J Clin Endocrinol Metab. 2022 May 3. pii: 6575101. doi: 10.1210.
    PubMed     Abstract available


    April 2022
  56. AGARWAL S, Shane E, Lang T, Shiau S, et al
    Spine volumetric BMD and strength in premenopausal idiopathic osteoporosis: Effects of teriparatide followed by denosumab.
    J Clin Endocrinol Metab. 2022 Apr 16. pii: 6569192. doi: 10.1210.
    PubMed     Abstract available


  57. YOO JE, Yoon JW, Park HE, Han K, et al
    Response to Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563352. doi: 10.1210.
    PubMed    


  58. ZHOU Q
    Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563351. doi: 10.1210.
    PubMed    


    March 2022
  59. FRARA S, Uygur MM, di Filippo L, Doga M, et al
    High Prevalence of Vertebral Fractures Associated with Preoperative GH Levels in Patients with recent Diagnosis of Acromegaly.
    J Clin Endocrinol Metab. 2022 Mar 29. pii: 6555665. doi: 10.1210.
    PubMed     Abstract available


  60. BORN C, Jakob F, Shojaa M, Kohl M, et al
    Effects of hormone therapy and exercise on bone mineral density in healthy women - A systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2022 Mar 24. pii: 6553368. doi: 10.1210.
    PubMed     Abstract available


  61. PENA DIAS J, Piggott DA, Sun J, Wehbeh L, et al
    SHBG, bone mineral density and physical function among injection drug users with and without HIV and HCV.
    J Clin Endocrinol Metab. 2022 Mar 16. pii: 6549479. doi: 10.1210.
    PubMed     Abstract available


    February 2022
  62. BALEANU F, Moreau M, Charles A, Iconaru L, et al
    Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study.
    J Clin Endocrinol Metab. 2022 Feb 17. pii: 6530319. doi: 10.1210.
    PubMed     Abstract available


    January 2022
  63. COLL JC, Garceau E, Leslie WD, Genest M, et al
    Prevalence of Vertebral Fractures in Adults with Type 1 Diabetes: DenSiFy Study (Diabetes Spine Fractures).
    J Clin Endocrinol Metab. 2022 Jan 28. pii: 6517001. doi: 10.1210.
    PubMed     Abstract available


  64. KLINE GA, Morin SN, Lix LM, Leslie WD, et al
    Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:491-499.
    PubMed     Abstract available


    December 2021
  65. QUESTER J, Nethander M, Eriksson A, Ohlsson C, et al
    Endogenous DHEAS is Causally Linked with Lumbar Spine Bone Mineral Density and Forearm Fractures in Women.
    J Clin Endocrinol Metab. 2021 Dec 22. pii: 6479181. doi: 10.1210.
    PubMed     Abstract available


  66. COSENTINI D, Grisanti S, Hadoux J, Libe R, et al
    Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461116. doi: 10.1210.
    PubMed     Abstract available


  67. WANG B, Wang Z, Poundarik AA, Zaki MJ, et al
    Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.
    J Clin Endocrinol Metab. 2021 Dec 9. pii: 6458464. doi: 10.1210.
    PubMed     Abstract available


    November 2021
  68. YOO JE, Yoon JW, Park HE, Han K, et al
    Blood pressure variability and the risk of fracture: a nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Nov 28. pii: 6445180. doi: 10.1210.
    PubMed     Abstract available


  69. SHANE E, Shiau S, Recker RR, Lappe JM, et al
    Denosumab After Teriparatide in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2021 Nov 24. pii: 6437931. doi: 10.1210.
    PubMed     Abstract available


  70. DAWOOD NB, Tseng CH, Nguyen DT, Yan KL, et al
    Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    J Clin Endocrinol Metab. 2021;106:e4993-e5000.
    PubMed     Abstract available


    October 2021

  71. Corrigendum to: Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6410701. doi: 10.1210.
    PubMed    


    September 2021
  72. FERRARI S
    Short or long-term osteoporosis therapy with denosumab ?
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375342. doi: 10.1210.
    PubMed    


  73. SHIEH A, Ruppert KM, Greendale GA, Lian Y, et al
    Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women.
    J Clin Endocrinol Metab. 2021 Sep 19. pii: 6372418. doi: 10.1210.
    PubMed     Abstract available


    August 2021
  74. VIOLA V, Tramontana F, Leanza G
    Letter to the Editor from Viola Viola: "Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis".
    J Clin Endocrinol Metab. 2021 Aug 14. pii: 6352412. doi: 10.1210.
    PubMed    


  75. KARAKILIC E, Saygili ES
    Letter to the Editor From Karakilic and Saygili:" Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes".
    J Clin Endocrinol Metab. 2021 Aug 13. pii: 6350455. doi: 10.1210.
    PubMed    


  76. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Response letter to the Editor from Dr. Viola et al. "Diminishing value from multiple serial bone densitometry in women receiving antiresorptive medication for osteoporosis."
    J Clin Endocrinol Metab. 2021 Aug 7. pii: 6345421. doi: 10.1210.
    PubMed    


  77. CROMER SJ, Yu EW
    Challenges and opportunities for osteoporosis care during the COVID-19 pandemic.
    J Clin Endocrinol Metab. 2021 Aug 3. pii: 6337853. doi: 10.1210.
    PubMed     Abstract available


    July 2021
  78. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    PubMed     Abstract available


  79. KUZMA M, Vanuga P, Sagova I, Pavai D, et al
    Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.
    J Clin Endocrinol Metab. 2021 Jul 16. pii: 6322668. doi: 10.1210.
    PubMed     Abstract available


  80. SCHMITZ D, Ek WE, Berggren E, Hoglund J, et al
    Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320117. doi: 10.1210.
    PubMed     Abstract available


  81. WARD LM, Ma J, Robinson ME, Scharke M, et al
    Osteoporotic Fractures and Vertebral Body Reshaping in Children with Glucocorticoid-Treated Rheumatic Disorders.
    J Clin Endocrinol Metab. 2021 Jul 7. pii: 6316730. doi: 10.1210.
    PubMed     Abstract available


  82. WARD LM, Choudhury A, Alos N, Cabral DA, et al
    Zoledronic acid versus placebo in pediatric glucocorticoid-induced osteoporosis: A randomized double-blind phase 3 trial.
    J Clin Endocrinol Metab. 2021 Jul 6. pii: 6316209. doi: 10.1210.
    PubMed     Abstract available


  83. LING CW, Miao Z, Xiao ML, Zhou H, et al
    The Association of Gut Microbiota with Osteoporosis is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313243. doi: 10.1210.
    PubMed     Abstract available


  84. MITCHELL A, Fall T, Melhus H, Lind L, et al
    Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313244. doi: 10.1210.
    PubMed     Abstract available


    June 2021
  85. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  86. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  87. CHAPURLAT R
    Of the Futility of Repeating BMD Measurement in Treated Osteoporotic Women.
    J Clin Endocrinol Metab. 2021 Jun 17. pii: 6303538. doi: 10.1210.
    PubMed    


    May 2021
  88. KIM JA, Lee JS, Song E, Roh E, et al
    Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
    PubMed     Abstract available


  89. ZAWORSKI C, Cheah J, Koff MF, Breighner R, et al
    MRI-based texture analysis of trabecular bone for opportunistic screening of skeletal fragility.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6276953. doi: 10.1210.
    PubMed     Abstract available


  90. MAKRAS P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, et al
    The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.
    J Clin Endocrinol Metab. 2021 May 12. pii: 6274510. doi: 10.1210.
    PubMed     Abstract available


  91. ZHU J, Briganti EM
    Letter to the Editor from Jasmine Zhu: Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2021 May 6. pii: 6268612. doi: 10.1210.
    PubMed    



  92. Corrigendum to: "Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT".
    J Clin Endocrinol Metab. 2021 May 4. pii: 6263815. doi: 10.1210.
    PubMed    


    April 2021
  93. SHIEH A, Karlamangla AS, Huang MH, Han W, et al
    Faster lumbar spine bone loss in midlife predicts subsequent fracture independent of starting bone mineral density.
    J Clin Endocrinol Metab. 2021 Apr 27. pii: 6254916. doi: 10.1210.
    PubMed     Abstract available


  94. CIARDULLO S, Muraca E, Zerbini F, Manzoni G, et al
    NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population.
    J Clin Endocrinol Metab. 2021 Apr 20. pii: 6241840. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  95. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Diminishing value from multiple serial bone densitometry in women receiving anti-resorptive medication for osteoporosis.
    J Clin Endocrinol Metab. 2021 Mar 30. pii: 6204740. doi: 10.1210.
    PubMed     Abstract available


  96. REEVES KW, Vieyra G, Grimes NP, Meliker J, et al
    Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6180137. doi: 10.1210.
    PubMed     Abstract available


  97. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    PubMed     Abstract available


  98. XUE S, Zhang Y, Qiao W, Zhao Q, et al
    An Updated Reference for Calculating Bone Mineral Density T-Scores.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178347. doi: 10.1210.
    PubMed     Abstract available


  99. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
    Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
    PubMed     Abstract available


  100. GONG R, Xiao HM, Zhang YH, Zhao Q, et al
    Identification and Functional Characterization of Metabolites for Bone Mass in Peri-/Post-menopausal Chinese Women.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6161511. doi: 10.1210.
    PubMed     Abstract available


    February 2021

  101. Corrigendum to: "Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health Initiative".
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146952. doi: 10.1210.
    PubMed    


  102. QU Z, Yang F, Yan Y, Hong J, et al
    Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2021 Feb 13. pii: 6134779. doi: 10.1210.
    PubMed     Abstract available


  103. CIPRIANI C, Minisola S, Bilezikian JP, Diacinti D, et al
    Vertebral Fracture Assessment in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132444. doi: 10.1210.
    PubMed     Abstract available


  104. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
    In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
    J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  105. KONG SH, Kim JH, Shin CS
    Serum Spermidine as a Novel Potential Predictor for Fragility Fractures.
    J Clin Endocrinol Metab. 2021;106:e582-e591.
    PubMed     Abstract available


  106. MISRA M, Bredella MA
    Bone Metabolism in Adolescents Undergoing Bariatric Surgery.
    J Clin Endocrinol Metab. 2021;106:326-336.
    PubMed     Abstract available


  107. DREYER P, Palomo T, Brandao CMA, Vieira JGH, et al
    Letter to the Editor from Dreyer, et al: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 22. pii: 6114543. doi: 10.1210.
    PubMed    


  108. YUAN S, Wan ZH, Cheng SL, Michaelsson K, et al
    Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jan 19. pii: 6104229. doi: 10.1210.
    PubMed     Abstract available



  109. Corrigendum to: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 13. pii: 6094895. doi: 10.1210.
    PubMed    


  110. HANNEMANN A, Nauck M, Volzke H, Weidner H, et al
    Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
    J Clin Endocrinol Metab. 2021;106:e288-e299.
    PubMed     Abstract available


    November 2020
  111. FENG SH, Huang YP, Yeh KC, Pan SL, et al
    Osteoporosis and the risk of Parkinson's disease: A nationwide propensity score-matched longitudinal follow-up study.
    J Clin Endocrinol Metab. 2020 Nov 25. pii: 6000490. doi: 10.1210.
    PubMed     Abstract available


  112. BROADWELL A, Chines A, Ebeling PR, Franek E, et al
    Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2020 Nov 19. pii: 5992310. doi: 10.1210.
    PubMed     Abstract available


  113. HOFSO D, Hillestad TOW, Halvorsen E, Fatima F, et al
    Bone mineral density and bone turnover after sleeve gastrectomy and gastric bypass, a randomized controlled trial.
    J Clin Endocrinol Metab. 2020 Nov 5. pii: 5956311. doi: 10.1210.
    PubMed     Abstract available


  114. CHARLIER S, Vavanikunnel J, Becker C, Jick SS, et al
    Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
    J Clin Endocrinol Metab. 2020 Nov 3. pii: 5952698. doi: 10.1210.
    PubMed     Abstract available


    October 2020
  115. TSOURDI E, Zillikens MC, Meier C, Body JJ, et al
    Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
    J Clin Endocrinol Metab. 2020 Oct 26. pii: 5939974. doi: 10.1210.
    PubMed     Abstract available


  116. DI FILIPPO L, Formenti AM, Doga M, Pedone E, et al
    Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes.
    J Clin Endocrinol Metab. 2020 Oct 21. pii: 5923308. doi: 10.1210.
    PubMed     Abstract available


    September 2020
  117. KREZ A, Agarwal S, Bucovsky M, McMahon DJ, et al
    Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906394. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  118. YEAP BB, Alfonso H, Chubb SAP, Center JR, et al
    U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    April 2020
  119. NETHANDER M, Pettersson-Kymmer U, Vandenput L, Lorentzon M, et al
    BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  120. GREY A, Horne A, Gamble G, Mihov B, et al
    Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  121. CIPRIANI C, Bilezikian JP
    Osteoanabolics Versus Antiresorptives: Which First?
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    December 2019
  122. SHIEH A, Greendale GA, Cauley JA, Karlamangla AS, et al
    The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
    J Clin Endocrinol Metab. 2019 Dec 16. pii: 5678661. doi: 10.1210.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.